Skip to main content

Table 2 Donor characteristics

From: A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation

 

ATG (n = 15)

DZM (n = 15)

P value

Age (years)

35 ± 5

35 ± 4

0.9

Sex (male/female)

11/4

10/5

1.0

Height (cm)

172 ± 3

172 ± 3

0.9

Weight (kg)

78 ± 5

86 ± 4

0.2

Body mass index (kg/m2)

26 ± 1

29 ± 1

0.1

Donor/recipient weight ratio

1.01 ± 0.05

1.08 ± 0.09

0.5

Donor ischemic time (min)

254 ± 22

249 ± 24

0.9